(Q44583967)

English

Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide

scientific article published in September 2003

Statements

Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide (English)
Eugenio Cammilluzzi
Giuseppe Lepidini

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit